SLC2A1 and colorectal carcinoma: METTL3-mediated m6A modification in the glucose transporter protein type 1 (GLUT1, also named SLC2A1) enhances its mRNA translation, which promotes glucose uptake and subsequently lactate production, leading to CRC progression (Chen et al., 2021).